Literature DB >> 7126417

Atenolol reduces blood pressure and FEV in normal subjects.

R W Fuller, P J Vallance.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7126417      PMCID: PMC1427631          DOI: 10.1111/j.1365-2125.1982.tb02005.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Effects of oral propranolol in normal subjects.

Authors:  M M LeWinter; M H Crawford; J S Karliner; R A ORourke
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

2.  Blockade of cardiac and renal beta-receptors by low dose propranolol in normal subjects. Clues to its antihypertensive effect.

Authors:  R Davies; T G Pickering; A Morganti; M Wilson; J H Laragh
Journal:  Br Heart J       Date:  1979-03

3.  Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise.

Authors:  G Planz; R Planz
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

4.  USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

Authors:  B N PRICHARD; P M GILLAM
Journal:  Br Med J       Date:  1964-09-19

5.  Effect of beta-adrenergic receptor blockade with propranolol on the response of plasma catecholamines and renin activity to upright tilting in normal subjects.

Authors:  R Vandongen; L Davidson; L J Beilin; A E Barden
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

  5 in total
  2 in total

1.  beta-adrenoceptor blockers reduce blood pressure in normal subjects.

Authors:  P Turner
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

2.  The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers.

Authors:  J C Mucklow; S Kuhn
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.